DCGI RELAXES NORMS FOR CLEARING VACCINES
02
Jun
DCGI RELAXES NORMS FOR CLEARING VACCINES Subject: Governance Context: India’s apex drug regulator Tuesday waived the requirement for foreign companies to conduct post-launch bridging trials and test the quality and stability of their Covid-19 vaccines here if they have approvals from specific countries or health bodies Concept: Drugs Controller General of India (DCGI) […]